… interchangeable biosimilar insulin glargine pens supplied by Biocon Biologics. The insulin, a long … CalRx moving quickly to lower insulin costs while pursuing other prescription … Access California and the CalRx Insulin Patient Advisory Council. Allison Hardt …

… Newsom announcing that CalRx biosimilar insulin glargine pens will be available … agreement with Biocon Biologics complements Civica Rx’s broader insulin development strategy … biosimilar versions of insulin glargine and rapid-acting insulin under the CalRx …

… will begin selling affordable insulin under its own label … only state making lower-cost insulin available. The nonprofit Civica … overdose crisis. For the insulin development, the state entered … year deal with Civica and Biocon Biologics in early 2023. …

… arrangement where Biocon Biologics will manufacture and supply Insulin Glargine medicine … continue to directly commercialize Biocon Biologics’ own Insulin Glargine-yfgn medicine, … announced that Biocon Biologics will provide Civica with Insulin Aspart drug …

… Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen … 1, 2026. The CalRx-branded insulin glargine pens will be interchangeable … capped consumer cost-sharing for insulin at $35 for a month …

… .11% in Fortis Malar Hospitals. Biocon: Biocon Biologics expanded its partnership with … to launch a private-label insulin Glargine in the U.S …

… that cheaper, state-made insulin for diabetics, an endeavor … by producing its own insulin, which around 40 million … press conference announcing $11 insulin and prescription drugs with the … through a partnership with Biocon Biologics. When Newsom announced …

… arrangement where Biocon Biologics will manufacture and supply Insulin Glargine medicine … continue to directly commercialize Biocon Biologics' own Insulin Glargine-yfgn medicine … mixed and rapid acting insulins. Shares of Biocon Limited was last trading …

… 2026, CalRx-branded biosimilar insulin glargine pens will be available … for its own affordable insulin supply. Through a partnership … Rx and Biocon Biologics, the state’s CalRx insulin will … action to tackle the insulin affordability crisis,” said Elizabeth …

… ; Newsom added.   The insulin glargine pen agreement with Biocon Biologics complements Civica … Rx's broader insulin development …